Development of Novel Therapies, Models, and Biomarkers for Osteoclast-Related Diseases

Henrik Löfvall

Avdelningen för molekylärmedicin och genterapi

Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

346 Nedladdningar (Pure)

5 Artikel i vetenskaplig tidskrift

5 resultat

2019
GPDPLQ1237—A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in vitro
Löfvall, H., Katri, A., Dąbrowska, A., Karsdal, M. A., Luo, Y., He, Y., Manon-Jensen, T., Dziegiel, M. H., Bay-Jensen, A.-C., Thudium, C. S. & Henriksen, K., 2019, I: Scientific Reports. 9, 3050.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Fil
202 Nedladdningar (Pure)
2018
Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes
Löfvall, H., Newbould, H., Karsdal, M. A., Dziegiel, M. H., Richter, J., Henriksen, K. & Thudium, C. S., 2018 apr. 10, I: Arthritis Research and Therapy. 20, 1, 67.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Targeting NSG Mice Engrafting Cells with a Clinically Applicable Lentiviral Vector Corrects Osteoclasts in Infantile Malignant Osteopetrosis
Moscatelli, I., Löfvall, H., Schneider Thudium, C., Rothe, M., Montano, C., Kertész, Z., Sirin, M., Schulz, A., Schambach, A., Henriksen, K. & Richter, J., 2018, I: Human Gene Therapy. 29, 8, s. 938-949
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
2017
Forced expression of human macrophage colony-stimulating factor in CD34⁺ cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro
Montano, C., Thudium, C. S., Löfvall, H., Moscatelli, I., Schambach, A., Henriksen, K. & Richter, J., 2017 feb. 3, I: European Journal of Haematology.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
2016
Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene Therapy
Thudium, C. S., Moscatelli, I., Löfvall, H., Kertész, Z., Montano, C., Bjurström, C. F., Karsdal, M. A., Schulz, A., Richter, J. & Henriksen, K., 2016, I: Calcified Tissue International. 99, 6, s. 638-648 11 s.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Development of Novel Therapies, Models, and Biomarkers for Osteoclast-Related Diseases

Forskningsoutput

Sökresultat

GPDPLQ1237—A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in vitro

Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes

Targeting NSG Mice Engrafting Cells with a Clinically Applicable Lentiviral Vector Corrects Osteoclasts in Infantile Malignant Osteopetrosis

Forced expression of human macrophage colony-stimulating factor in CD34+ cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro

Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene Therapy

Forced expression of human macrophage colony-stimulating factor in CD34⁺ cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro